세계의 시클로덱스트린 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 최종 용도별, 지역별 전망과 예측(2024-2031년)

Global Cyclodextrin Market Size, Share & Trends Analysis Report By Type (Beta-Cyclodextrin, Alpha-Cyclodextrin, and Gamma-Cyclodextrin), By End-use, By Regional Outlook and Forecast, 2024 - 2031

US $ 3,600 ￦ 5,155,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320 ￦ 6,187,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048 ￦ 8,661,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

시클로덱스트린 시장 규모는 예측 기간 중 5.6%의 CAGR로 시장 성장하며, 2031년까지 5억 430만 달러에 달할 것으로 예상되고 있습니다. 2023년에 시장은 873.18톤에 달하며, 17.7%의 성장을 달성했습니다(2020-2023년).

또한 도시화가 진행되고 소득이 증가함에 따라 식생활의 선호도가 편의식품과 가공식품으로 크게 변화하고 있습니다. 이들은 식품 및 음료 산업에서 향료, 향료 및 기타 기능성 성분의 캡슐화제로 광범위하게 사용되고 있습니다. 따라서 중산층 인구 증가와 도시화가 시장 성장을 촉진하고 있습니다.

그러나 이들은 난용성 약물과 포접 복합체를 독자적으로 형성하여 약물의 용해도와 생체 이용률을 향상시킬 수 있습니다. 이러한 특성은 약물전달 시스템에서 특히 유용하며, 유효성분(API)의 용해도와 생체 이용률을 높여 약물의 효능과 치료 효과를 향상시킬 수 있습니다. 이처럼 약물전달 시스템의 혁신이 시장 성장을 주도하고 있습니다.

Outlook 유형

유형에 따라 시장은 알파 시클로덱스트린, 베타 시클로덱스트린, 감마 시클로덱스트린으로 나뉩니다. 알파 시클로 덱스트린 부문은 2023년 시장에서 24.3%의 매출 점유율을 차지했습니다. 알파 시클로덱스트린은 특정 용도에 특히 적합한 고유 한 특성을 가지고 있습니다. 또한 수량 측면에서 알파 변형 부문은 2023년에 72.57 톤의 시클로 덱스트린을 사용했습니다.

최종 용도 전망

최종 용도에 따라 시장은 식품, 제약, 화장품 및 퍼스널케어, 화학, 섬유, 기타로 분류됩니다. 화학 부문은 2023년 시장에서 15.4%의 성장률을 유지했습니다. 이들은 화학 산업에서 광범위한 용도를 가지고 있습니다. 이들은 다양한 화합물의 착화제, 용해제, 안정제 및 담체로 사용됩니다. 또한 양적으로 화학 부문은 2023년에 138.44 톤의 시클로덱스트린을 사용했습니다.

지역 전망

지역별로는 북미, 유럽, 아시아태평양 및 LAMEA 지역이 2023년 시장에서 27.1%의 매출 점유율을 차지할 것으로 예상됩니다. 아시아태평양 소비자들은 건강과 웰빙 트렌드에 대한 인식이 높아지면서 기능성 식품, 건강 보조 식품, 건강상의 이점을 추가한 퍼스널케어 제품에 대한 수요가 급증하고 있습니다. 2031년까지 아시아태평양에서는 1,22,154.38톤의 시클로덱스트린이 사용될 것으로 예상됩니다.

목차

제1장 시장 범위와 조사 방법

• 시장의 정의
• 목적
• 시장 범위
• 세분화
• 조사 방법

제2장 시장 요약

• 주요 하이라이트

제3장 시장 개요

• 서론
  • 개요
    • 시장 구성과 시나리오
• 시장에 영향을 미치는 주요 요인
  • 시장 촉진요인
  • 시장 기회
  • 시장 억제요인
  • 시장이 해결해야 할 과제
• Porter's Five Forces 분석

제4장 세계 시장 : 유형별

• 세계의 베타 시클로덱스트린 시장 : 지역별
• 세계의 알파 시클로덱스트린 시장 : 지역별
• 세계의 감마 시클로덱스트린 시장 : 지역별

제5장 세계 시장 : 최종 용도별

• 세계의 의약품 시장 : 지역별
• 세계의 식품 시장 : 지역별
• 세계의 화장품·퍼스널케어 시장 : 지역별
• 세계의 화학제품 시장 : 지역별
• 세계의 섬유 시장 : 지역별
• 세계의 기타 시장 : 지역별

제6장 세계 시장 : 지역별

• 북미
  • 북미의 시장 : 국가별
    • 미국
    • 캐나다
    • 멕시코
    • 기타 북미
• 유럽
  • 유럽의 시장 : 국가별
    • 독일
    • 영국
    • 프랑스
    • 러시아
    • 스페인
    • 이탈리아
    • 기타 유럽
• 아시아태평양
  • 아시아태평양의 시장 : 국가별
    • 중국
    • 일본
    • 인도
    • 한국
    • 싱가포르
    • 말레이시아
    • 기타 아시아태평양
• 라틴아메리카·중동 및 아프리카
  • 라틴아메리카·중동 및 아프리카의 시장 : 국가별
    • 브라질
    • 아르헨티나
    • 아랍에미리트
    • 사우디아라비아
    • 남아프리카공화국
    • 나이지리아
    • 기타 라틴아메리카·중동 및 아프리카

제7장 기업 개요

• Midas Pharma GmbH
• Wacker Chemie AG
• Roquette Freres SA
• Cambrex Corporation
• Wellona Pharma
• Cayman Chemical Company, Inc
• Cyclolab Kft
• Ligand Pharmaceuticals Incorporated
• Tocopharm Co Limited
• Merck KGaA

제8장 시클로덱스트린 시장의 성공 필수 조건

KSA

영문 목차

영문목차

The Global Cyclodextrin Market size is expected to reach $504.3 million by 2031, rising at a market growth of 5.6% CAGR during the forecast period. In the year 2023, the market attained a volume of 873.18 Tonnes, experiencing a growth of 17.7% (2020-2023).

Cyclodextrins are well-known for improving the solubility and bioavailability of poorly soluble drugs. Therefore, the pharmaceutical segment would acquire 34.8% revenue share by 2031. Moreover, the pharmaceutical segment utilized 289.62 Tonnes of Cyclodextrin in 2023. Many active pharmaceutical ingredients (APIs) have limited solubility in aqueous solutions, hindering their absorption and efficacy in pharmaceutical formulations.

Many drugs used to treat infectious diseases face challenges related to poor solubility, which can hinder their effectiveness. Cyclodextrins, with their ability to form inclusion complexes, can improve the solubility of these drugs. In addition, these increase their aqueous solubility by encapsulating poorly soluble drugs within their hydrophobic cavity, making them more bioavailable and efficacious. Thus, increasing drug formulation for infectious diseases drives the market's growth.

Additionally, as urbanization progresses and incomes rise, there's a notable shift in dietary preferences towards convenience and processed foods. These find extensive applications in the food and beverage industry as encapsulants for flavors, fragrances, and other functional ingredients. Therefore, the growing middle-class population and urbanization propel the market's growth.

However, these can uniquely form inclusion complexes with poorly soluble drugs, improving their solubility and bioavailability. This property is particularly valuable in drug delivery systems were increasing the solubility and bioavailability of active pharmaceutical ingredients (APIs) can enhance drug efficacy and therapeutic outcomes. Thus, drug delivery system innovations are propelling the market's growth.

Type Outlook

Based on type, the market is divided into alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin. The alpha-cyclodextrin segment attained 24.3% revenue share in the market in 2023. Alpha-cyclodextrin offers unique properties that make it particularly suitable for certain applications. Moreover, in terms of volume, the alpha-variant segment utilized 72.57 tonnes of Cyclodextrin in 2023.

End-use Outlook

On the basis of end-use, the market is segmented into food, pharmaceutical, cosmetics & personal care, chemical, textile, and others. The chemical segment held 15.4% growth rate in the market in 2023. These have a wide range of applications in the chemical industry. They are utilized as complex agents, solubilizers, stabilizers, and carriers for various chemical compounds. Moreover, in terms of volume, the chemical segment utilized 138.44 Tonnes of Cyclodextrin in 2023.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 27.1% revenue share in the market. Consumers in the Asia Pacific region is becoming increasingly aware of health and wellness trends, leading to a surge in demand for functional foods, dietary supplements, and personal care products with added health benefits. In terms of volume, the Asia Pacific region would utilize 1,22,154.38 tonnes of Cyclodextrin by 2031.

List of Key Companies Profiled

• Midas Pharma Gmbh
• Wacker Chemie AG
• Roquette Freres SA
• Cambrex Corporation
• Wellona Pharma
• Cayman Chemical Company, Inc.
• Cyclolab Kft.
• Ligand Pharmaceuticals Incorporated
• Tocopharm Co. Limited
• Merck KGaA

Global Cyclodextrin Market Report Segmentation

By Type (Volume, Tonnes, USD Million, 2020-2031)

• Beta-Cyclodextrin
• Alpha-Cyclodextrin
• Gamma-Cyclodextrin

By End-use (Volume, Tonnes, USD Million, 2020-2031)

• Pharmaceutical
• Food
• Cosmetics & Personal Care
• Chemical
• Textile
• Others

By Geography (Volume, Tonnes, USD Million, 2020-2031)

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global Cyclodextrin Market, by Type
  • 1.4.2Global Cyclodextrin Market, by End-use
  • 1.4.3Global Cyclodextrin Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Opportunities
  • 3.2.3Market Restraints
  • 3.2.4Market Challenges
• 3.3Porter Five Forces Analysis

Chapter 4.Global Cyclodextrin Market by Type

• 4.1Global Beta-Cyclodextrin Market by Region
• 4.2Global Alpha-Cyclodextrin Market by Region
• 4.3Global Gamma-Cyclodextrin Market by Region

Chapter 5.Global Cyclodextrin Market by End-use

• 5.1Global Pharmaceutical Market by Region
• 5.2Global Food Market by Region
• 5.3Global Cosmetics & Personal Care Market by Region
• 5.4Global Chemical Market by Region
• 5.5Global Textile Market by Region
• 5.6Global Others Market by Region

Chapter 6.Global Cyclodextrin Market by Region

• 6.1North America Cyclodextrin Market
  • 6.1.1North America Cyclodextrin Market by Type
    • 6.1.1.1North America Beta-Cyclodextrin Market by Country
    • 6.1.1.2North America Alpha-Cyclodextrin Market by Country
    • 6.1.1.3North America Gamma-Cyclodextrin Market by Country
  • 6.1.2North America Cyclodextrin Market by End-use
    • 6.1.2.1North America Pharmaceutical Market by Country
    • 6.1.2.2North America Food Market by Country
    • 6.1.2.3North America Cosmetics & Personal Care Market by Country
    • 6.1.2.4North America Chemical Market by Country
    • 6.1.2.5North America Textile Market by Country
    • 6.1.2.6North America Others Market by Country
  • 6.1.3North America Cyclodextrin Market by Country
    • 6.1.3.1US Cyclodextrin Market
      • 6.1.3.1.1US Cyclodextrin Market by Type
      • 6.1.3.1.2US Cyclodextrin Market by End-use
    • 6.1.3.2Canada Cyclodextrin Market
      • 6.1.3.2.1Canada Cyclodextrin Market by Type
      • 6.1.3.2.2Canada Cyclodextrin Market by End-use
    • 6.1.3.3Mexico Cyclodextrin Market
      • 6.1.3.3.1Mexico Cyclodextrin Market by Type
      • 6.1.3.3.2Mexico Cyclodextrin Market by End-use
    • 6.1.3.4Rest of North America Cyclodextrin Market
      • 6.1.3.4.1Rest of North America Cyclodextrin Market by Type
      • 6.1.3.4.2Rest of North America Cyclodextrin Market by End-use
• 6.2Europe Cyclodextrin Market
  • 6.2.1Europe Cyclodextrin Market by Type
    • 6.2.1.1Europe Beta-Cyclodextrin Market by Country
    • 6.2.1.2Europe Alpha-Cyclodextrin Market by Country
    • 6.2.1.3Europe Gamma-Cyclodextrin Market by Country
  • 6.2.2Europe Cyclodextrin Market by End-use
    • 6.2.2.1Europe Pharmaceutical Market by Country
    • 6.2.2.2Europe Food Market by Country
    • 6.2.2.3Europe Cosmetics & Personal Care Market by Country
    • 6.2.2.4Europe Chemical Market by Country
    • 6.2.2.5Europe Textile Market by Country
    • 6.2.2.6Europe Others Market by Country
  • 6.2.3Europe Cyclodextrin Market by Country
    • 6.2.3.1Germany Cyclodextrin Market
      • 6.2.3.1.1Germany Cyclodextrin Market by Type
      • 6.2.3.1.2Germany Cyclodextrin Market by End-use
    • 6.2.3.2UK Cyclodextrin Market
      • 6.2.3.2.1UK Cyclodextrin Market by Type
      • 6.2.3.2.2UK Cyclodextrin Market by End-use
    • 6.2.3.3France Cyclodextrin Market
      • 6.2.3.3.1France Cyclodextrin Market by Type
      • 6.2.3.3.2France Cyclodextrin Market by End-use
    • 6.2.3.4Russia Cyclodextrin Market
      • 6.2.3.4.1Russia Cyclodextrin Market by Type
      • 6.2.3.4.2Russia Cyclodextrin Market by End-use
    • 6.2.3.5Spain Cyclodextrin Market
      • 6.2.3.5.1Spain Cyclodextrin Market by Type
      • 6.2.3.5.2Spain Cyclodextrin Market by End-use
    • 6.2.3.6Italy Cyclodextrin Market
      • 6.2.3.6.1Italy Cyclodextrin Market by Type
      • 6.2.3.6.2Italy Cyclodextrin Market by End-use
    • 6.2.3.7Rest of Europe Cyclodextrin Market
      • 6.2.3.7.1Rest of Europe Cyclodextrin Market by Type
      • 6.2.3.7.2Rest of Europe Cyclodextrin Market by End-use
• 6.3Asia Pacific Cyclodextrin Market
  • 6.3.1Asia Pacific Cyclodextrin Market by Type
    • 6.3.1.1Asia Pacific Beta-Cyclodextrin Market by Country
    • 6.3.1.2Asia Pacific Alpha-Cyclodextrin Market by Country
    • 6.3.1.3Asia Pacific Gamma-Cyclodextrin Market by Country
  • 6.3.2Asia Pacific Cyclodextrin Market by End-use
    • 6.3.2.1Asia Pacific Pharmaceutical Market by Country
    • 6.3.2.2Asia Pacific Food Market by Country
    • 6.3.2.3Asia Pacific Cosmetics & Personal Care Market by Country
    • 6.3.2.4Asia Pacific Chemical Market by Country
    • 6.3.2.5Asia Pacific Textile Market by Country
    • 6.3.2.6Asia Pacific Others Market by Country
  • 6.3.3Asia Pacific Cyclodextrin Market by Country
    • 6.3.3.1China Cyclodextrin Market
      • 6.3.3.1.1China Cyclodextrin Market by Type
      • 6.3.3.1.2China Cyclodextrin Market by End-use
    • 6.3.3.2Japan Cyclodextrin Market
      • 6.3.3.2.1Japan Cyclodextrin Market by Type
      • 6.3.3.2.2Japan Cyclodextrin Market by End-use
    • 6.3.3.3India Cyclodextrin Market
      • 6.3.3.3.1India Cyclodextrin Market by Type
      • 6.3.3.3.2India Cyclodextrin Market by End-use
    • 6.3.3.4South Korea Cyclodextrin Market
      • 6.3.3.4.1South Korea Cyclodextrin Market by Type
      • 6.3.3.4.2South Korea Cyclodextrin Market by End-use
    • 6.3.3.5Singapore Cyclodextrin Market
      • 6.3.3.5.1Singapore Cyclodextrin Market by Type
      • 6.3.3.5.2Singapore Cyclodextrin Market by End-use
    • 6.3.3.6Malaysia Cyclodextrin Market
      • 6.3.3.6.1Malaysia Cyclodextrin Market by Type
      • 6.3.3.6.2Malaysia Cyclodextrin Market by End-use
    • 6.3.3.7Rest of Asia Pacific Cyclodextrin Market
      • 6.3.3.7.1Rest of Asia Pacific Cyclodextrin Market by Type
      • 6.3.3.7.2Rest of Asia Pacific Cyclodextrin Market by End-use
• 6.4LAMEA Cyclodextrin Market
  • 6.4.1LAMEA Cyclodextrin Market by Type
    • 6.4.1.1LAMEA Beta-Cyclodextrin Market by Country
    • 6.4.1.2LAMEA Alpha-Cyclodextrin Market by Country
    • 6.4.1.3LAMEA Gamma-Cyclodextrin Market by Country
  • 6.4.2LAMEA Cyclodextrin Market by End-use
    • 6.4.2.1LAMEA Pharmaceutical Market by Country
    • 6.4.2.2LAMEA Food Market by Country
    • 6.4.2.3LAMEA Cosmetics & Personal Care Market by Country
    • 6.4.2.4LAMEA Chemical Market by Country
    • 6.4.2.5LAMEA Textile Market by Country
    • 6.4.2.6LAMEA Others Market by Country
  • 6.4.3LAMEA Cyclodextrin Market by Country
    • 6.4.3.1Brazil Cyclodextrin Market
      • 6.4.3.1.1Brazil Cyclodextrin Market by Type
      • 6.4.3.1.2Brazil Cyclodextrin Market by End-use
    • 6.4.3.2Argentina Cyclodextrin Market
      • 6.4.3.2.1Argentina Cyclodextrin Market by Type
      • 6.4.3.2.2Argentina Cyclodextrin Market by End-use
    • 6.4.3.3UAE Cyclodextrin Market
      • 6.4.3.3.1UAE Cyclodextrin Market by Type
      • 6.4.3.3.2UAE Cyclodextrin Market by End-use
    • 6.4.3.4Saudi Arabia Cyclodextrin Market
      • 6.4.3.4.1Saudi Arabia Cyclodextrin Market by Type
      • 6.4.3.4.2Saudi Arabia Cyclodextrin Market by End-use
    • 6.4.3.5South Africa Cyclodextrin Market
      • 6.4.3.5.1South Africa Cyclodextrin Market by Type
      • 6.4.3.5.2South Africa Cyclodextrin Market by End-use
    • 6.4.3.6Nigeria Cyclodextrin Market
      • 6.4.3.6.1Nigeria Cyclodextrin Market by Type
      • 6.4.3.6.2Nigeria Cyclodextrin Market by End-use
    • 6.4.3.7Rest of LAMEA Cyclodextrin Market
      • 6.4.3.7.1Rest of LAMEA Cyclodextrin Market by Type
      • 6.4.3.7.2Rest of LAMEA Cyclodextrin Market by End-use

Chapter 7.Company Profiles

• 7.1Midas Pharma GmbH
  • 7.1.1Company Overview
• 7.2Wacker Chemie AG
  • 7.2.1Company Overview
  • 7.2.2Financial Analysis
  • 7.2.3Segmental and Regional Analysis
  • 7.2.4Research & Development Expenses
  • 7.2.5Recent strategies and developments:
    • 7.2.5.1Acquisition and Mergers:
  • 7.2.6SWOT Analysis
• 7.3Roquette Freres SA
  • 7.3.1Company Overview
  • 7.3.2Recent strategies and developments:
    • 7.3.2.1Partnerships, Collaborations, and Agreements:
  • 7.3.3SWOT Analysis
• 7.4Cambrex Corporation
  • 7.4.1Company Overview
  • 7.4.2SWOT Analysis
• 7.5Wellona Pharma
  • 7.5.1Company Overview
• 7.6Cayman Chemical Company, Inc.
  • 7.6.1Company Overview
  • 7.6.2SWOT Analysis
• 7.7Cyclolab Kft.
  • 7.7.1Company Overview
• 7.8Ligand Pharmaceuticals Incorporated
  • 7.8.1Company Overview
  • 7.8.2Financial Analysis
  • 7.8.3Research & Development Expenses
• 7.9Tocopharm Co. Limited
  • 7.9.1Company Overview
• 7.10.Merck KGaA
  • 7.10.1Company Overview
  • 7.10.2Financial Analysis
  • 7.10.3Segmental and Regional Analysis
  • 7.10.4Research & Development Expense
  • 7.10.5SWOT Analysis

Chapter 8.Winning Imperatives of Cyclodextrin Market

관련자료